Breast Cancer

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA
FDA
FDA Approves First Gene Therapy in the US
08/30/2017
The FDA has approved the first CAR T-cell therapy available in the United States for the treatment of certain pediatric patients.
08/30/2017
FDA
FDA
FDA Approves First Gene Therapy in the US
08/30/2017
The FDA has approved the first CAR T-cell therapy available in the United States for the treatment of certain pediatric patients.
08/30/2017
FDA
FDA
FDA Approves New Antibacterial Drug
08/30/2017
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
08/30/2017
FDA
FDA
FDA Approves New Antibacterial Drug
08/30/2017
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
08/30/2017
FDA
FDA
FDA Approves New Antibacterial Drug
08/30/2017
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
08/30/2017
FDA
FDA
FDA Approves First US Treatment for Chagas Disease
08/30/2017
After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.
08/30/2017
FDA
FDA
FDA Approves First US Treatment for Chagas Disease
08/30/2017
After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.
08/30/2017
FDA
FDA
FDA Approves First US Treatment for Chagas Disease
08/30/2017
After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.
08/30/2017
Rheumatologic disorders
Rheumatologic disorders
FDA Approves Biosimilar to Humira
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017
Rheumatologic disorders
Rheumatologic disorders
FDA Approves Biosimilar to Humira
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017